Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Miyo Goto"'
Autor:
Ken Sagou, Makoto Ito, Yuma Kawamura, Shun Ukai, Miyo Goto, Nobuaki Fukushima, Kazutaka Ozeki, Ryuichi Fukuyama, Akio Kohno
Publikováno v:
Clinical Case Reports, Vol 9, Iss 2, Pp 878-882 (2021)
Abstract BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor burden, such as high white blood cell count or splenomegaly, should be carefully considered to prevent T
Externí odkaz:
https://doaj.org/article/d656c0953ef6444f83ce58bd49861b1a
Autor:
Shun Ukai, Miyo Goto, Yuma Kawamura, Makoto Ito, Akio Kohno, Shiori Iida, Ken Sagou, Kazutaka Ozeki, Nobuaki Fukushima
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 10:183-189
Autor:
Akio Kohno, Ryuichi Fukuyama, Miyo Goto, Yuma Kawamura, Kazutaka Ozeki, Ken Sagou, Makoto Ito, Nobuaki Fukushima, Shun Ukai
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 2, Pp 878-882 (2021)
Clinical Case Reports, Vol 9, Iss 2, Pp 878-882 (2021)
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor burden, such as high white blood cell count or splenomegaly, should be carefully considered to prevent TLS.
Publikováno v:
International Journal of Hematology. 113:63-72
Tacrolimus (TAC) is essential for prophylaxis of acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic cell transplantation (allo-HSCT). We have sometimes observed large fluctuations in TAC concentration. However, links between the v
Publikováno v:
International Journal of Hematology. 112:697-706
One major cause of treatment-related death is transplant-associated thrombotic microangiopathy (TA-TMA). Because of difficulties with diagnosis, many criteria for TA-TMA have been defined. Some patients clinically suspected as TA-TMA have been treate
Autor:
Masahide Osaki, Takanobu Morishita, Motohito Okabe, Marie Ohbiki, Takahiko Sato, Yoon-ha Lee, Yukiyasu Ozawa, Tatsunori Goto, Koichi Miyamura, Yuuka Kawaguchi, Miyo Goto, Hiroaki Araie
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:2509-2516
Noninfectious transplantation-related complications (TRCs) such as graft-versus-host disease (GVHD) and endothelial cell damage (TRC-EC) are critical after allogeneic hematopoietic stem cell transplantation. Tacrolimus (TAC) is used to control GVHD.
Autor:
Miyo, Goto, Nobuaki, Fukushima, Shiori, Iida, Makoto, Ito, Yuma, Kawamura, Shun, Ukai, Ken, Sagou, Ryuichi, Fukuyama, Akio, Kohno, Kazutaka, Ozeki
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(4)
Acute myeloid leukemia (AML) associated with double-minute chromosomes (dmin) is a rare condition and has a poor prognosis. A 68-year-old man with leukocytosis and thrombocytopenia was admitted to our hospital. Bone marrow aspiration showed that 79.5
Autor:
Yukiyasu Ozawa, Aika Seto, Marie Ohbiki, Koichi Miyamura, Miyo Goto, Takahiko Sato, Tatsunori Goto, Takanobu Morishita
Publikováno v:
International journal of hematology. 114(6)
Infection is one of the major causes of death in hematopoietic stem cell transplantation (HSCT) survivors. Precise assessments of immune function after HSCT will be critical in establishing appropriate treatment and prophylaxis, such as re-vaccinatio
Autor:
Yuka Kawaguchi, Koichi Miyamura, Takanobu Morishita, Miyo Goto, Tatsunori Goto, Yukiyasu Ozawa, Yoon-ha Lee, Tomoe Ichiki, Marie Ohbiki, Masahide Osaki, Motohito Okabe, Hiroaki Araie
Publikováno v:
Clinical transplantationREFERENCES. 34(10)
BACKGROUND Early tacrolimus (TAC) concentrations correlate with the risk of acute graft-versus-host disease (aGVHD); however, whether the variability of early TAC concentrations after allo-HSCT governs the occurrence of aGVHD remains unknown. Here, w
Autor:
Akio Kohno, Yuma Kawamura, Ken Sagou, Kazutaka Ozeki, Shun Ukai, Miyo Goto, Ryuichi Fukuyama, Makoto Ito, Nobuaki Fukushima
Blastic plasmacytoid dendritic cell neoplasm is a rare disease with difficulty in diagnosis, and clinical courses of patients with BPDCN vary widely. We report a case of a 63-year-old man with BPDCN showing severe tumor lysis syndrome (TLS). BPDCN wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37edcb7e30a7299f4bb392d932787f06
https://doi.org/10.22541/au.158878800.01605449
https://doi.org/10.22541/au.158878800.01605449